Skylight Health Group Inc (NQ: SLHG )
0.5847 UNCHANGED Last Price Updated: 4:00 PM EDT, Aug 24, 2022 Add to My Watchlist
All News about Skylight Health Group Inc
Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up period...
Why Is Super Micro Computer Higher By More Than 13%? 42 Stocks Moving In Thursday's Mid-Day Session
July 21, 2022
Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares jumped 364.3% to $23.22. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending...
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.
From Traders News Source
EXCLUSIVE: Skylight Health To Buy NeighborMD To Expand In Florida, Enter Medicare Advantage Global Risk
May 03, 2022
Skylight Health Group Inc (NASDAQ: SLHG) has agreed to acquire NeighborMD (NMD) for $8 million. Skylight has also arranged a $20 million debt line facility with a New York-based credit lender.
Skylight Health Research Program Reveals Participation In 10 Studies, Close To $300,000 In Revenue, Key Partnerships And More In Latest Clinical Research Update
May 02, 2022
Image sourced from Unsplash This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
40 Stocks Moving In Thursday's Mid-Day Session
December 02, 2021
Gainers Biofrontera Inc. (NASDAQ: BFRI) surged 39% to $6.02. Biofrontera announced Notice of Allowance for U.S. patent titled 'Illumination for Photodynamic Therapy.'...
61 Biggest Movers From Yesterday
December 02, 2021
Gainers Arbutus Biopharma Corporation (NASDAQ: ABUS) shares jumped 44.1% to close $4.61 on above-average volume on Wednesday. The Patent Trial and Appeals Board has turned down...
50 Stocks Moving In Wednesday's Mid-Day Session
December 01, 2021
Gainers Arbutus Biopharma Corporation (NASDAQ: ABUS) climbed 91.7% to $6.14 on above-average volume on Wednesday. The Patent Trial and Appeals Board has turned down Moderna's...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following